These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 3075357)
1. Comparative studies of drug susceptibility of five strains of Trypanosoma cruzi in vivo and in vitro. Neal RA; van Bueren J Trans R Soc Trop Med Hyg; 1988; 82(5):709-14. PubMed ID: 3075357 [TBL] [Abstract][Full Text] [Related]
2. Role of glutathione in the susceptibility of Trypanosoma cruzi to drugs. Moncada C; Repetto Y; Aldunate J; Letelier ME; Morello A Comp Biochem Physiol C Comp Pharmacol Toxicol; 1989; 94(1):87-91. PubMed ID: 2576749 [TBL] [Abstract][Full Text] [Related]
3. Trypanocidal activity of N-isopropyl oxamate on cultured epimastigotes and murine trypanosomiasis using different Trypanosoma cruzi strains. Chena MA; Elizondo S; Rodríguez-Páez L; Nogueda B; Baeza I; Wong C J Enzyme Inhib Med Chem; 2005 Apr; 20(2):189-97. PubMed ID: 15968824 [TBL] [Abstract][Full Text] [Related]
4. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease. Filardi LS; Brener Z Trans R Soc Trop Med Hyg; 1987; 81(5):755-9. PubMed ID: 3130683 [TBL] [Abstract][Full Text] [Related]
5. Trypanosoma cruzi: In vitro effect of aspirin with nifurtimox and benznidazole. López-Muñoz R; Faúndez M; Klein S; Escanilla S; Torres G; Lee-Liu D; Ferreira J; Kemmerling U; Orellana M; Morello A; Ferreira A; Maya JD Exp Parasitol; 2010 Feb; 124(2):167-71. PubMed ID: 19735656 [TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo trypanocidal activity of the ethyl esters of N-allyl and N-propyl oxamates using different Trypanosoma cruzi strains. Aguirre-Alvarado C; Zaragoza-Martínez F; Rodríguez-Páez L; Nogueda B; Baeza I; Wong C J Enzyme Inhib Med Chem; 2007 Apr; 22(2):227-33. PubMed ID: 17518350 [TBL] [Abstract][Full Text] [Related]
7. Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection. Gulin JEN; Bisio M; Rocco DM; Altcheh J; Solana ME; García-Bournissen F Exp Parasitol; 2018 Mar; 186():50-58. PubMed ID: 29448038 [TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility to benznidazole, nifurtimox and posaconazole of Trypanosoma cruzi isolates from Paraguay. Acosta N; Yaluff G; López E; Bobadilla C; Ramírez A; Fernández I; Escobar P Biomedica; 2020 Dec; 40(4):749-763. PubMed ID: 33275352 [TBL] [Abstract][Full Text] [Related]
10. [Effects of nifurtimox, benznidazole, and beta-lapachone on the metabolism of DNA, RNA and proteins in Trypanosoma cruzi]. Goijman SG; Stoppani AO Rev Argent Microbiol; 1983; 15(4):193-204. PubMed ID: 6086046 [TBL] [Abstract][Full Text] [Related]
11. Buthionine sulfoximine increases the toxicity of nifurtimox and benznidazole to Trypanosoma cruzi. Faundez M; Pino L; Letelier P; Ortiz C; López R; Seguel C; Ferreira J; Pavani M; Morello A; Maya JD Antimicrob Agents Chemother; 2005 Jan; 49(1):126-30. PubMed ID: 15616285 [TBL] [Abstract][Full Text] [Related]
12. Effects of nifurtimox and benznidazole upon glutathione and trypanothione content in epimastigote, trypomastigote and amastigote forms of Trypanosoma cruzi. Maya JD; Repetto Y; Agosín M; Ojeda JM; Tellez R; Gaule C; Morello A Mol Biochem Parasitol; 1997 May; 86(1):101-6. PubMed ID: 9178272 [No Abstract] [Full Text] [Related]
13. A rapid method for testing in vivo the susceptibility of different strains of Trypanosoma cruzi to active chemotherapeutic agents. Filardi LS; Brener Z Mem Inst Oswaldo Cruz; 1984; 79(2):221-5. PubMed ID: 6443014 [TBL] [Abstract][Full Text] [Related]
14. Trypanocidal effect of the benzyl ester of N-propyl oxamate: a bi-potential prodrug for the treatment of experimental Chagas disease. Wong-Baeza C; Nogueda-Torres B; Serna M; Meza-Toledo S; Baeza I; Wong C BMC Pharmacol Toxicol; 2015 Apr; 16():10. PubMed ID: 25896924 [TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of susceptible and naturally resistant strains of Trypanosoma cruzi to benznidazole and nifurtimox. Murta SM; Gazzinelli RT; Brener Z; Romanha AJ Mol Biochem Parasitol; 1998 Jun; 93(2):203-14. PubMed ID: 9662705 [TBL] [Abstract][Full Text] [Related]
16. Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial. Villar JC; Herrera VM; Pérez Carreño JG; Váquiro Herrera E; Castellanos Domínguez YZ; Vásquez SM; Cucunubá ZM; Prado NG; Hernández Y Trials; 2019 Jul; 20(1):431. PubMed ID: 31307503 [TBL] [Abstract][Full Text] [Related]
18. The effect of benznidazole dose among the efficacy outcome in the murine animal model. A quantitative integration of the literature. Molina I; Perin L; Aviles AS; de Abreu Vieira PM; da Silva Fonseca K; Cunha LM; Carneiro CM Acta Trop; 2020 Jan; 201():105218. PubMed ID: 31610148 [TBL] [Abstract][Full Text] [Related]
19. Activities of the triazole derivative SCH 56592 (posaconazole) against drug-resistant strains of the protozoan parasite Trypanosoma (Schizotrypanum) cruzi in immunocompetent and immunosuppressed murine hosts. Molina J; Martins-Filho O; Brener Z; Romanha AJ; Loebenberg D; Urbina JA Antimicrob Agents Chemother; 2000 Jan; 44(1):150-5. PubMed ID: 10602737 [TBL] [Abstract][Full Text] [Related]
20. [Isoenzymatic pattern of Trypanosoma cruzi Y strain after specific chemotherapy]. Silva RC; Santiago CM; Pontes AL; Andrade SG Mem Inst Oswaldo Cruz; 1989; 84(1):81-6. PubMed ID: 2108307 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]